CancerNCT07008781
A Youth-led Intervention to Reduce Healthcare Disparities in Cancer Screening
A study testing Youth-led cancer screening intervention in people with Cancer, run by Rutgers, The State University of New Jersey at 1 site in United States.
Trial summary
This study engages youth as health advocates to increase cancer screening in their community. The study will evaluate the effectiveness of a youth-led intervention on cancer screening awareness in adults who are overdue for cancer screening. Read more about this study
- Who is it for?
- Ages 15 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- Cancer
- What is being tested?
- Youth-led cancer screening intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 84 participants
- Where
- 1 siteUnited States
- Study dates
- 30 May 2025to Feb 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 80 years
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Student at New Brunswick Health Sciences Technology High School (15-18 years) and their adult family members (18+ years old) who are NJ residents.
- Adults must be eligible for at least one cancer screening other than skin (see below).
- Participants must be fluent in either English or Spanish and the youth must speak the same language as the adult.
- Breast: 40-74 year old women Cervical: 21-65 year old women with a cervix (have not had a hysterectomy) Colorectal: 45-75 year olds Prostate: 50 to 69 year old men (start at 45 for black males) Lung: 50 to 80 year olds who currently smoke or quit within the past 15 years
- Overall:
- 21-75 year old women 45-75 year old men 76-80 year olds who currently smoke or quit within the past 15 years
Who cannot join
- Students less than 15 years old.
- Adults not eligible for a cancer screening of interest.
- Unable to speak fluent English or Spanish.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
New Brunswick Health Sciences Technology High School
New Brunswick, New Jersey, 08901
Jeremiah Clifford, 732-745-5300 ext. 4062, jeremiah_clifford@nbpsnj.net
About this study
This study engages youth as health advocates to increase cancer screening in their community. The study will evaluate the effectiveness of a youth-led intervention on cancer screening awareness in adults who are overdue for cancer screening.
- Conditions
- Cancer
- Being tested
- Youth-led cancer screening intervention
- Keywords
- cancer screening, adolescents, high school, community-based research, community health, Hispanic/Latino community
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Youth-led cancer screening interventionBehavioural
High school students will be trained as health advocates and then facilitate discussions about cancer screening recommendations and risk factors with adults in their community. High school students (15-18 years old) from the local community will be recruited for this study, and each student will recruit adults that they live with or are part of their community (i.e. parent) who are eligible for cancer screening. The adult plus youth dyads will all undergo the same youth-led intervention in which the youth will utilize motivational interviewing to discuss cancer screening recommendations and risk factors with their adults and help their adults enroll in cancer screening through ScreenNJ, a community organization that aims to increase cancer screening in New Jersey, reduce cancer mortality rates, and reduce disparities.
| Study group | Role | What they receive |
|---|---|---|
| Youth-led cancer screening intervention | Experimental | High school students will be trained as health advocates and then facilitate discussions about cancer screening recommendations and risk factors with adults in their community. High school students (15-18 years old) from the local community will be recruited for this study, and each student will recruit adults that they live with or are part of their community (i.e. parent) who are eligible for cancer screening. The adult plus youth dyads will all undergo the same youth-led intervention in which the youth will utilize motivational interviewing to discuss cancer screening recommendations and risk factors with their adults and help their adults enroll in cancer screening through ScreenNJ, a community organization that aims to increase cancer screening in New Jersey, reduce cancer mortality rates, and reduce disparities. Receives: Behavioral: Youth-led cancer screening intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Rate of Cancer Screening
% of adults who schedule or conduct cancer screening 2 weeks post-intervention
Measured: 2 weeks post-intervention
Secondary outcomes (5)
Change in Cancer Screening Knowledge- Adult
Change in Pre-/post-cancer screening knowledge in the adult using a 7-item assessment that the study team created. Higher scores indicate more knowledge.
Measured: Baseline and 3 days later
Change in Cancer Screening Knowledge- Youth
Change in Pre-/post-cancer screening knowledge in the youth using a 7-item assessment that the study team created. Higher scores indicate more knowledge.
Measured: Baseline and after intervention ends
Change in Youth Self-Efficacy
Change in Pre-/post youth self-efficacy using a 10-item assessment that the study team created and includes some questions adapted from Patient Activation Measure (PAM-10). Higher scores indicate more self-efficacy.
Measured: Baseline and after intervention ends
Change in Adult Activation
Change in Pre-/post adult activation using a 5-item assessment adapted from Patient Activation Measure (PAM-10). Higher scores indicate more activation.
Measured: Baseline and 3 days later
Proportion of adults who are overdue for each cancer type
Proportion of adults who are overdue for each cancer type
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Jun 2025
- Study start30 May 2025
- Primary completionDec 2026 (estimated)
- Study completionFeb 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- More trials run by Rutgers, The State University of New JerseyThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 84 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Rutgers, The State University of New Jersey
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sara Heinert, PhD, MPH, Rutgers, The State University of New Jersey
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07008781
- Sponsor's protocol ID
- Pro2025000586
- Status last verified
- Apr 2026
- First submitted
- 5 May 2025
- Last updated
- 28 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Youth-led Intervention to Reduce Healthcare Disparities in Cancer Screening
- ClinicalTrials.gov ID
- NCT07008781
- Acronym / sponsor ID
- Pro2025000586
- Conditions
- Cancer
- Keywords
- cancer screening, adolescents, high school, community-based research, community health, Hispanic/Latino community
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 84 participants (estimated)
- Lead sponsor
- Rutgers, The State University of New JerseyUniversity, hospital or other
- Study start
- 30 May 2025 (actual)
- Primary completion
- Dec 2026 (estimated)
- Study completion
- Feb 2027 (estimated)
- First posted
- 6 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study engages youth as health advocates to increase cancer screening in their community. The study will evaluate the effectiveness of a youth-led intervention on cancer screening awareness in adults who are overdue for cancer screening.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Youth-led cancer screening intervention | Experimental | Behavioral: Youth-led cancer screening interventionHigh school students will be trained as health advocates and then facilitate discussions about cancer screening recommendations and risk factors with adults in their community. High school students (15-18 years old) from the local community will be recruited for this study, and each student will recruit adults that they live with or are part of their community (i.e. parent) who are eligible for cancer screening. The adult plus youth dyads will all undergo the same youth-led intervention in which the youth will utilize motivational interviewing to discuss cancer screening recommendations and risk factors with their adults and help their adults enroll in cancer screening through ScreenNJ, a community organization that aims to increase cancer screening in New Jersey, reduce cancer mortality rates, and reduce disparities. |
Who may qualify
- Ages
- 15 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (6 listed)
- Student at New Brunswick Health Sciences Technology High School (15-18 years) and their adult family members (18+ years old) who are NJ residents.
- Adults must be eligible for at least one cancer screening other than skin (see below).
- Participants must be fluent in either English or Spanish and the youth must speak the same language as the adult.
- Breast: 40-74 year old women Cervical: 21-65 year old women with a cervix (have not had a hysterectomy) Colorectal: 45-75 year olds Prostate: 50 to 69 year old men (start at 45 for black males) Lung: 50 to 80 year olds who currently smoke or quit within the past 15 years
- 21-75 year old women 45-75 year old men 76-80 year olds who currently smoke or quit within the past 15 years
Key exclusion criteria (3 listed)
- Students less than 15 years old.
- Adults not eligible for a cancer screening of interest.
- Unable to speak fluent English or Spanish.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Youth-led cancer screening interventionHigh school students will be trained as health advocates and then facilitate discussions about cancer screening recommendations and risk factors with adults in their community. High school students (15-18 years old) from the local community will be recruited for this study, and each student will recruit adults that they live with or are part of their community (i.e. parent) who are eligible for cancer screening. The adult plus youth dyads will all undergo the same youth-led intervention in which the youth will utilize motivational interviewing to discuss cancer screening recommendations and risk factors with their adults and help their adults enroll in cancer screening through ScreenNJ, a community organization that aims to increase cancer screening in New Jersey, reduce cancer mortality rates, and reduce disparities. | Behavioural | Youth-led cancer screening intervention |
Primary outcome
Rate of Cancer Screening
Time frame: 2 weeks post-intervention
% of adults who schedule or conduct cancer screening 2 weeks post-intervention
5 secondary outcomes
Change in Cancer Screening Knowledge- Adult
Time frame: Baseline and 3 days later
Change in Cancer Screening Knowledge- Youth
Time frame: Baseline and after intervention ends
Change in Youth Self-Efficacy
Time frame: Baseline and after intervention ends
Change in Adult Activation
Time frame: Baseline and 3 days later
Proportion of adults who are overdue for each cancer type
Time frame: Baseline
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Apr 2026.
- Individual participant dataSharing planned: No
Related trials for Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Youth-led cancer screening intervention in people with Cancer, run by Rutgers, The State University of New Jersey at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 28 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Sara Heinert, PhD, MPH (732-235-7872, sara.heinert@rutgers.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rate of Cancer Screening (time frame: 2 weeks post-intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2026.